A prospective crossover randomized controlled trial evaluating the efficacy of texture and color enhancement imaging (TXI) for identification of colorectal neoplasms

A prospective crossover randomized controlled trial evaluating the efficacy of texture and color enhancement imaging (TXI) for identification of colorectal neoplasms - TXI study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000048038

Enrollment

700

Registered

2022-06-13

Start date

2022-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal neoplasms

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients over 20 years old undergoing colonoscopy

Exclusion criteria

Exclusion criteria: 1. Patients in disagreement with informed consent. 2. Patients with inadequate bowel preparation (BBPS: score0 or 1). 3. Patients with previous right-sided colorectal resection. 4. Patients with inflammatory bowel disease. 5. Patients with familial adenomatous polyposis. 6. Patients with Peytz-Jeghers syndrome. 7. Patients with hereditary polyposis syndromes. 8. Other, patients deemed by the treating physician to be ineligible for inclusion in the study.

Design outcomes

Primary

Measure	Time frame
Adenoma (polyp) detection rate	—

Secondary

Measure	Time frame
colorectal neoplasms detected per patient % Increase in detection rate	—

Countries

Japan

Contacts

Public ContactEiji Sakai

Yokohama Sakae Kyosai Hospital Department of Gastroenterology

eiji-not_found@goo.jp045-891-2171

Outcome results